1. INTRODUCTION 1.1. Overview of the DEXA EQUIPMENT Market 1.2. MARKET SEGMENTATION & COVERAGE 1.2.1. Currency and Pricing 1.2.2. Limitation 1.2.3. Stakeholders 2. RESEARCH METHODOLOGY 2.1. Key takeaways 2.2. ARRIVING AT THE global DEXA EQUIPMENT market 2.2.1. Market crackdown approach 2.2.2. Company revenue and market share analysis 2.2.3. Data triangulation 2.2.4. KEY DATA POINTS FROM PRIMARY SOURCEs 2.2.5. KEY DATA POINTS FROM SECONDARY SOURCEs 2.2.6. EPIDEMIOLOGY DATA FORECASTING MODEL 2.4. GLOBAL DEXA EQUIPMENT market: RESEARCH SNAPSHOT 2.5. ASSUMPTIONS 3. MARKET LANDSCAPE SUMMARY 4. PREMIUM INSIGHTS 4.1. OVERVIEW 4.2. Global DEXA EQUIPMENT Market: KEY PRIMARY INSIGHTS 4.3. MARKET OVERVIEW 4.3.1. DRIVERS 4.3.2. RESTRAINTS 4.3.3. OPPURTUNITIES 4.3.4. THREATS 4.4. Key Market Trends and Upcoming Technologies 5. DEXA EQUIPMENT MARKET, EPIDEMIOLOGY STUDIES 5.1. OVERVIEW 5.2. PREVALENT POPULATION OF OSTEOPOROSIS: MEN VS WOMEN; (2010 – 2025) 5.2.1. NORTH AMERICA, BY COUNTRY 5.2.2. EUROPE, BY COUNTRY 5.2.3. ASIA-PACIFIC, BY COUNTRY 5.2.4. REST OF THE WORLD, BY COUNTRY 5.2.5. SOURCES BIBLIOGRAPHY 5.3. PREVALENT POPULATION OF DIAGNOSED OSTEOPOROSIS: MEN VS WOMEN; (2010 – 2025) 5.3.1. NORTH AMERICA, BY COUNTRY 5.3.2. EUROPE, BY COUNTRY 5.3.3. ASIA-PACIFIC, BY COUNTRY 5.3.4. REST OF THE WORLD, BY COUNTRY 5.3.5. SOURCES BIBLIOGRAPHY 5.4. INCIDENCE OF VERTEBRAL FRACTURES: MEN VS WOMEN; (2010 – 2025) 5.4.1. NORTH AMERICA, BY COUNTRY 5.4.2. EUROPE, BY COUNTRY 5.4.3. ASIA-PACIFIC, BY COUNTRY 5.4.4. REST OF THE WORLD, BY COUNTRY 5.4.5. SOURCES BIBLIOGRAPHY 5.5. INCIDENCE OF HIP FRACTURES: MEN VS WOMEN; (2010 – 2025) 5.5.1. NORTH AMERICA, BY COUNTRY 5.5.2. EUROPE, BY COUNTRY 5.5.3. ASIA-PACIFIC, BY COUNTRY 5.5.4. REST OF THE WORLD, BY COUNTRY 5.5.5. SOURCES BIBLIOGRAPHY 5.6. PREVALENCE OF OBESITY; (2010 – 2025) 5.6.1. NORTH AMERICA, BY COUNTRY 5.6.2. EUROPE, BY COUNTRY 5.6.3. ASIA-PACIFIC, BY COUNTRY 5.6.4. REST OF THE WORLD, BY COUNTRY 5.6.5. SOURCES BIBLIOGRAPHY 5.7. PREVALENCE OF AORTIC CALCIFICATION; (2010 – 2025) 5.7.1. NORTH AMERICA, BY COUNTRY 5.7.2. EUROPE, BY COUNTRY 5.7.3. SOURCES BIBLIOGRAPHY 6. DEXA EQUIPMENT MARKET, BY COMPETITIVE MARKET ASSESMENT 6.1. OVERVIEW 6.2. BONE DENSITOMETRY: QUANTITATIVE ct VS DEXA 6.3. BONE DENSITOMETRY: QUANTITATIVE ULTRASOUND VS DEXA 6.4. BODY COMPOSITION ANALYZERS: BODY IMPEDANCE ANALYZERS VS DEXA 6.5. BODY COMPOSITION ANALYZERS: HYDROSTATIC WEIGHING VS DEXA 7. DEXA EQUIPMENT MARKET, BY PRODUCT TYPE 7.1. OVERVIEW 7.2. CENTRAL DEXA BONE DENSITOMETER (2014 – 2022) 7.2.1. MARKET VALUE (USD MILLION) 7.2.1. MARKET VOLUME (UNITS SOLD) 7.3. PERIPHERAL DEXA BONE DENSITOMETER (2014 – 2022) 7.3.1. MARKET VALUE (USD MILLION) 7.3.1. MARKET VOLUME (UNITS SOLD) 8. DEXA EQUIPMENT MARKET, BY APPLICATION 8.1. OVERVIEW 8.2. BODY COMPOSITION ANALYSIS (2014 – 2022) 8.3. BONE DENSITOMETRY (2014 – 2022) 8.4. FRACTURE DIAGNOSIS (2014 – 2022) 8.5. FRACTURE RISK ASSESMENT (2014 – 2022) 9. DEXA EQUIPMENT MARKET, BY END-USER 9.1. OVERVIEW 9.2. HOSPITALS (2014 – 2022) 9.3. CLINICS (2014 – 2022) 9.4. MOBILE HEALTH CENTERS (2014 – 2022) 9.5. OVER THE COUNTER (2014 – 2022) 10. DEXA EQUIPMENT MARKET, BY GEOGRAPHY 10.1. COUNTRYWISE DUAL EMISSION X-RAY ABSORPTIOMETRY EQUIPMENT MARKET, (2014 – 2022) (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY) (MARKET VALUE (USD MILLION), MARKET VOLUME (UNITS SOLD), AVERAGE SELLING PRICE USD)) 10.1.1. NORTH AMERICA 10.1.1.1. U.S. 10.1.1.2. CANADA 10.1.1.3. MEXICO 10.1.2. EUROPE 10.1.2.1. GERMANY 10.1.2.2. FRANCE 10.1.2.3. U.K. 10.1.2.4. ITALY 10.1.2.5. SPAIN 10.1.2.6. RUSSIA 10.1.2.7. TURKEY 10.1.2.8. BELGIUM 10.1.2.9. NETHERLANDS 10.1.2.10. SWITZERLAND 10.1.2.11. REST OF EUROPE 10.1.3. ASIA-PACIFIC (APAC) 10.1.3.1. JAPAN 10.1.3.2. CHINA 10.1.3.3. SOUTH KOREA 10.1.3.4. INDIA 10.1.3.5. AUSTRALIA 10.1.3.6. SINGAPORE 10.1.3.7. THAILAND 10.1.3.8. MALAYSIA 10.1.3.9. INDONESIA 10.1.3.10. PHILIPPINES 10.1.3.11. REST OF APAC 10.1.4. SOUTH AMERICA 10.1.4.1. BRAZIL 10.1.4.2. REST OF SOUTH AMERICA 10.1.5. MIDDLE EAST AND AFRICA (MEA) 10.1.5.1. SOUTH AFRICA 10.1.5.2. SAUDI ARABIA 10.1.5.3. UNITED ARAB EMIRATES (U.A.E) 10.1.5.4. REST OF MEA 10.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES 11. DEXA EQUIPMENT MARKET: COMPETITIVE LANDSCAPE 11.1. GLOBAL dexa equipment MARKET: COMPANY SHARE ANALYSIS 11.2. U.S. dexa equipment MARKET: COMPANY SHARE ANALYSIS 11.3. EUROPE dexa equipment MARKET: COMPANY SHARE ANALYSIS 11.4. ASIA-PACIFIC dexa equipment MARKET: COMPANY SHARE ANALYSIS 11.5. South America dexa equipment MARKET: COMPANY SHARE ANALYSIS 11.6. MERGERS & ACQUISITIONS 11.7. NEW PRODUCT DEVELOPMENT & APPROVALS 11.8. REGULATORY CHANGES 12. DEXA EQUIPMENT MARKET, COMPANY PROFILES 12.1. Hologic, Inc. 12.1.1. OVERVIEW 12.1.2. SWOT ANALYSIS 12.1.3. PRODUCT PORTFOLIO 12.1.4. REVENUE ANALYSIS 12.1.5. ANALYSTS VIEW 12.2. GE HEALTHCARE 12.2.1. OVERVIEW 12.2.2. SWOT ANALYSIS 12.2.3. PRODUCT PORTFOLIO 12.2.4. REVENUE ANALYSIS 12.2.5. ANALYSTS VIEW 12.3. Osteometer Meditech Inc. 12.3.1. OVERVIEW 12.3.2. SWOT ANALYSIS 12.3.3. PRODUCT PORTFOLIO 12.3.4. REVENUE ANALYSIS 12.3.5. ANALYST VIEW 12.4. SWISSRAY INTERNATIONAL, INC. 12.4.1. OVERVIEW 12.4.2. SWOT ANALYSIS 12.4.3. PRODUCT PORTFOLIO 12.4.4. REVENUE ANALYSIS 12.4.5. ANALYSTS VIEW 12.5. MB TECH 12.5.1. OVERVIEW 12.5.2. SWOT ANALYSIS 12.5.3. PRODUCT PORTFOLIO 12.5.4. REVENUE ANALYSIS 12.5.5. ANALYSTS VIEW 12.6. DMS IMAGING 12.6.1. OVERVIEW 12.6.2. SWOT ANALYSIS 12.6.3. PRODUCT PORTFOLIO 12.6.4. REVENUE ANALYSIS 12.6.5. ANALYSTS VIEW 12.7. THE ACN SRL 12.7.1. OVERVIEW 12.7.2. SWOT ANALYSIS 12.7.3. PRODUCT PORTFOLIO 12.7.4. REVENUE ANALYSIS 12.7.5. ANALYSTS VIEW 12.8. DEMETECH AB 12.8.1. OVERVIEW 12.8.2. SWOT ANALYSIS 12.8.3. PRODUCT PORTFOLIO 12.8.4. REVENUE ANALYSIS 12.8.5. ANALYSTS VIEW 12.9. AMPALL CO.,LTD. 12.9.1. OVERVIEW 12.9.2. SWOT ANALYSIS 12.9.3. PRODUCT PORTFOLIO 12.9.4. REVENUE ANALYSIS 12.9.5. ANALYSTS VIEW 13. APPENDIX 14. ABOUT DATA BRIDGE MARKET RESEARCH